Halozyme Therapeutics, Inc. Stock Chart

Halozyme Therapeutics, Inc. (LSE) · Health Technology. stock live price and technical analysis view. Follow LSE data on Alerta Chart.

Checking data access...

About Halozyme Therapeutics, Inc.

LSE
Market Cap
$8.07B
P/E Ratio
16.16
Shares Out.
116.97M
Sector
Health Technology
Industry
Biotechnology

Halozyme Therapeutics, Inc. is a biopharmaceutical technology platform company. It engages in developing, manufacturing, and commercializing drug-device combination products using advanced auto-injector technology that are designed to provide commercial or functional advantages such as improved convenience and tolerability, and enhanced patient comfort and adherence. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA.

www.halozyme.com

Related Markets

Market Hub:Stocks Hub

Need more analysis tools?

With Alerta Chart Pro Terminal, you can follow 4 charts at the same time, see depth (order book) data and set 25 active alerts.

Start for Free
0J2O.GB (0J2O.GB) Stock Live Chart & Technical Analysis | Alerta Chart | Alerta Chart